Fonar Corp financial data

Symbol
FONR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
110 Marcus Dr, Melville, New York
State of incorporation
Delaware
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 894 % +10.3%
Debt-to-equity 30.2 % -8.38%
Return On Equity 7.1 % +1.28%
Return On Assets 5.39 % +3.06%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 106 M USD +11.8%
Weighted Average Number of Shares Outstanding, Basic 6.34 M shares -2.25%
Weighted Average Number of Shares Outstanding, Diluted 6.61 M shares -1.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 103 M USD +5.16%
Research and Development Expense 1.74 M USD +15.1%
Costs and Expenses 85 M USD +4.69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 20.3 M USD +21.3%
Income Tax Expense (Benefit) 5.63 M USD +80.8%
Net Income (Loss) Attributable to Parent 11 M USD +5.7%
Earnings Per Share, Basic 1.48 USD/shares -4.52%
Earnings Per Share, Diluted 0.55 USD/shares +71.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 136 M USD +11.3%
Property, Plant and Equipment, Net 19.3 M USD -15.5%
Operating Lease, Right-of-Use Asset 37.8 M USD +12.5%
Intangible Assets, Net (Excluding Goodwill) 3.18 M USD -9.02%
Goodwill 4.27 M USD 0%
Assets 210 M USD +5.17%
Accounts Payable, Current 1.68 M USD -2.5%
Liabilities, Current 14.5 M USD +4.15%
Long-term Debt and Lease Obligation 115 K USD -25.9%
Operating Lease, Liability, Noncurrent 36.5 M USD +11.8%
Liabilities 52.6 M USD +7.97%
Retained Earnings (Accumulated Deficit) -14.5 M USD +43.2%
Stockholders' Equity Attributable to Parent 166 M USD +5.46%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 157 M USD +4.26%
Liabilities and Equity 210 M USD +5.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.62 M USD -2.93%
Net Cash Provided by (Used in) Financing Activities -2.13 M USD -20.7%
Net Cash Provided by (Used in) Investing Activities -79 K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54 M USD +8.75%
Interest Paid, Excluding Capitalized Interest, Operating Activities 48 K USD +220%
Deferred Tax Assets, Valuation Allowance 364 K USD -17.6%
Deferred Tax Assets, Gross 10.4 M USD -21.7%
Operating Lease, Liability 37.4 M USD +17.7%
Payments to Acquire Property, Plant, and Equipment 63 K USD -93.3%
Property, Plant and Equipment, Gross 61.7 M USD +6.25%
Operating Lease, Liability, Current 3.64 M USD -8.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.35 M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.4 M USD +10.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 1.24 M USD +8.38%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.21 M USD +9.06%
Deferred Tax Assets, Operating Loss Carryforwards 2.77 M USD -42.6%
Deferred Federal Income Tax Expense (Benefit) 719 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.85 M USD +3.57%
Additional Paid in Capital 181 M USD -1.91%
Current Federal Tax Expense (Benefit) 1.13 M USD
Depreciation, Depletion and Amortization 4.73 M USD +8.74%
Deferred Tax Assets, Net of Valuation Allowance 7.04 M USD -35.5%
Interest Expense 76.1 K USD -40%